MIGUEL JOSÉ
MARTÍN JIMÉNEZ
Catedrático de universidad
Dana–Farber Cancer Institute
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (16)
2023
2022
-
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 3, pp. 282-293
2021
-
21-gene assay to inform chemotherapy benefit in node-positive breast cancer
New England Journal of Medicine, Vol. 385, Núm. 25, pp. 2336-2347
-
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Annals of Oncology, Vol. 32, Núm. 12, pp. 1571-1581
-
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
The Lancet Oncology, Vol. 22, Núm. 2, pp. 212-222
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR1, HER22, node-positive, high-risk, early breast cancer (monarchE)
Journal of Clinical Oncology, Vol. 38, Núm. 34, pp. 3987-3998
2019
2018
-
Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: Final analysis of the CALOR trial
Journal of Clinical Oncology, Vol. 36, Núm. 11, pp. 1073-1079
2014
-
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): A randomised trial
The Lancet Oncology, Vol. 15, Núm. 2, pp. 156-163
-
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
British Journal of Cancer, Vol. 111, Núm. 8, pp. 1532-1541
2013
-
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
Breast Cancer Research and Treatment, Vol. 138, Núm. 2, pp. 457-466
2012
-
Ixabepilone-associated peripheral neuropathy: Data from across the phase II and III clinical trials
Supportive Care in Cancer, Vol. 20, Núm. 11, pp. 2661-2668
2011
-
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials
The Lancet, Vol. 378, Núm. 9793, pp. 771-784
2010
-
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
Journal of the National Cancer Institute - Monographs, Vol. 41, pp. 162-177
2005
-
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
Annals of Oncology, Vol. 16, Núm. 10, pp. 1569-1583